Lithium carbonate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for lithium carbonate and what is the scope of freedom to operate?
Lithium carbonate
is the generic ingredient in seven branded drugs marketed by Noven Therap, Able, Alembic Ltd, Apotex Inc, Glenmark Pharms Ltd, Hetero Labs Ltd Iii, Hikma, Norvium Bioscience, Usl Pharma, Watson Labs, Solvay, Jds Pharms, Alembic, Glenmark Pharms Inc, Heritage Pharma, Hikma Intl Pharms, Mylan Pharms Inc, Unique, Ani Pharms, Bayer Pharms, Pfizer, and Sun Pharm Inds Inc, and is included in thirty-six NDAs. Additional information is available in the individual branded drug profile pages.There are thirteen drug master file entries for lithium carbonate. Twenty-four suppliers are listed for this compound.
Summary for lithium carbonate
| US Patents: | 0 |
| Tradenames: | 7 |
| Applicants: | 22 |
| NDAs: | 36 |
| Drug Master File Entries: | 13 |
| Finished Product Suppliers / Packagers: | 24 |
| Raw Ingredient (Bulk) Api Vendors: | 133 |
| Clinical Trials: | 99 |
| Patent Applications: | 5,475 |
| Drug Prices: | Drug price trends for lithium carbonate |
| What excipients (inactive ingredients) are in lithium carbonate? | lithium carbonate excipients list |
| DailyMed Link: | lithium carbonate at DailyMed |
Recent Clinical Trials for lithium carbonate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mental Health Services in the Capital Region, Denmark | Phase 4 |
| First Affiliated Hospital of Chongqing Medical University | Phase 1/Phase 2 |
| Second Xiangya Hospital of Central South University | Phase 1/Phase 2 |
Pharmacology for lithium carbonate
| Drug Class | Mood Stabilizer |
Medical Subject Heading (MeSH) Categories for lithium carbonate
Anatomical Therapeutic Chemical (ATC) Classes for lithium carbonate
US Patents and Regulatory Information for lithium carbonate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Pharms Ltd | LITHIUM CARBONATE | lithium carbonate | CAPSULE;ORAL | 079139-001 | Feb 3, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hikma | LITHIUM CARBONATE | lithium carbonate | TABLET;ORAL | 018558-001 | Jan 29, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Bayer Pharms | LITHANE | lithium carbonate | TABLET;ORAL | 018833-001 | Jul 18, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apotex Inc | LITHIUM CARBONATE | lithium carbonate | CAPSULE;ORAL | 076795-001 | Nov 22, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma Intl Pharms | LITHIUM CARBONATE | lithium carbonate | TABLET;ORAL | 078715-001 | Dec 28, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alembic Ltd | LITHIUM CARBONATE | lithium carbonate | CAPSULE;ORAL | 079159-001 | Jan 12, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Alembic Ltd | LITHIUM CARBONATE | lithium carbonate | CAPSULE;ORAL | 079159-003 | Jan 12, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for lithium carbonate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Ani Pharms | LITHOBID | lithium carbonate | TABLET, EXTENDED RELEASE;ORAL | 018027-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
